Works matching IS 15228517 AND DT 2018 AND VI 20 AND IP 6


Results: 23
    1

    Society News.

    Published in:
    Neuro-Oncology, 2018, v. 20, n. 6, p. 863, doi. 10.1093/neuonc/noy061
    Publication type:
    Article
    2
    3
    4
    5

    Radiomic subtyping improves disease stratification beyond key molecular, clinical, and standard imaging characteristics in patients with glioblastoma.

    Published in:
    Neuro-Oncology, 2018, v. 20, n. 6, p. 848, doi. 10.1093/neuonc/nox188
    By:
    • Kickingereder, Philipp;
    • Neuberger, Ulf;
    • Bonekamp, David;
    • Piechotta, Paula L.;
    • Götz, Michael;
    • Wick, Antje;
    • Sill, Martin;
    • Kratz, Annekathrin;
    • Shinohara, Russell T.;
    • Jones, David T. W.;
    • Radbruch, Alexander;
    • Muschelli, John;
    • Unterberg, Andreas;
    • Debus, Jürgen;
    • Schlemmer, Heinz-Peter;
    • Herold-Mende, Christel;
    • Pfister, Stefan;
    • von Deimling, Andreas;
    • Wick, Wolfgang;
    • Capper, David
    Publication type:
    Article
    6

    Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma.

    Published in:
    Neuro-Oncology, 2018, v. 20, n. 6, p. 838, doi. 10.1093/neuonc/nox202
    By:
    • Gan, Hui K.;
    • Reardon, David A.;
    • Lassman, Andrew B.;
    • Merrell, Ryan;
    • van den Bent, Martin;
    • Butowski, Nicholas;
    • Lwin, Zarnie;
    • Wheeler, Helen;
    • Fichtel, Lisa;
    • Scott, Andrew M.;
    • Gomez, Erica J.;
    • Fischer, JuDee;
    • Mandich, Helen;
    • Hao Xiong;
    • Ho-Jin Lee;
    • Munasinghe, Wijith P.;
    • Roberts-Rapp, Lisa A.;
    • Ansell, Peter J.;
    • Holen, Kyle D.;
    • Kumthekar, Priya
    Publication type:
    Article
    7

    Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation--the NCT Neuro Master Match (N<sup>2</sup>M<sup>2</sup>) pilot study.

    Published in:
    Neuro-Oncology, 2018, v. 20, n. 6, p. 826, doi. 10.1093/neuonc/nox216
    By:
    • Pfaff, Elke;
    • Kessler, Tobias;
    • Balasubramanian, Gnana Prakash;
    • Berberich, Anne;
    • Schrimpf, Daniel;
    • Wick, Antje;
    • Debus, Jürgen;
    • Unterberg, Andreas;
    • Bendszus, Martin;
    • Herold-Mende, Christel;
    • Capper, David;
    • Schenkel, Irini;
    • Eisenmenger, Andreas;
    • Dettmer, Susan;
    • Brors, Benedikt;
    • Platten, Michael;
    • Pfister, Stefan M.;
    • von Deimling, Andreas;
    • Jones, David T. W.;
    • Wick, Wolfgang
    Publication type:
    Article
    8
    9

    Molecular subtyping of tumors from patients with familial glioma.

    Published in:
    Neuro-Oncology, 2018, v. 20, n. 6, p. 810, doi. 10.1093/neuonc/nox192
    By:
    • Ruiz, Vanessa Y.;
    • Praska, Corinne E.;
    • Armstrong, Georgina;
    • Kollmeyer, Thomas M.;
    • Yamada, Seiji;
    • Decker, Paul A.;
    • Kosel, Matthew L.;
    • Eckel-Passow, Jeanette E.;
    • Lachance, Daniel H.;
    • Bainbridge, Matthew N.;
    • Melin, Beatrice S.;
    • Bondy, Melissa L.;
    • Jenkins, Robert B.
    Publication type:
    Article
    10
    11
    12

    An NF-κB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells.

    Published in:
    Neuro-Oncology, 2018, v. 20, n. 6, p. 776, doi. 10.1093/neuonc/nox234
    By:
    • Ius, Tamara;
    • Ciani, Yari;
    • Ruaro, Maria Elisabetta;
    • Isola, Miriam;
    • Sorrentino, Marisa;
    • Bulfoni, Michela;
    • Candotti, Veronica;
    • Correcig, Cecilia;
    • Bourkoula, Evgenia;
    • Manini, Ivana;
    • Pegolo, Enrico;
    • Mangoni, Damiano;
    • Marzinotto, Stefania;
    • Radovic, Slobodanka;
    • Toffoletto, Barbara;
    • Caponnetto, Federica;
    • Zanello, Andrea;
    • Mariuzzi, Laura;
    • Di Loreto, Carla;
    • Beltrami, Antonio Paolo
    Publication type:
    Article
    13

    A molecular cascade modulates MAP1B and confers resistance to mTOR inhibition in human glioblastoma.

    Published in:
    Neuro-Oncology, 2018, v. 20, n. 6, p. 764, doi. 10.1093/neuonc/nox215
    By:
    • Laks, Dan R.;
    • Oses-Prieto, Juan A.;
    • Alvarado, Alvaro G.;
    • Nakashima, Jonathan;
    • Chand, Shreya;
    • Azzam, Daniel B.;
    • Gholkar, Ankur A.;
    • Sperry, Jantzen;
    • Ludwig, Kirsten;
    • Condro, Michael C.;
    • Nazarian, Serli;
    • Cardenas, Anjelica;
    • Shih, Michelle Y. S.;
    • Damoiseaux, Robert;
    • France, Bryan;
    • Orozco, Nicholas;
    • Visnyei, Koppany;
    • Crisman, Thomas J.;
    • Gao, Fuying;
    • Torres, Jorge Z.
    Publication type:
    Article
    14

    PRMT5 as a druggable target for glioblastoma therapy.

    Published in:
    Neuro-Oncology, 2018, v. 20, n. 6, p. 753, doi. 10.1093/neuonc/nox206
    By:
    • Banasavadi-Siddegowda, Yeshavanth Kumar;
    • Welker, Alessandra M.;
    • Min An;
    • Xiaozhi Yang;
    • Wei Zhou;
    • Guqin Shi;
    • Imitola, Jaime;
    • Chenglong Li;
    • Hsu, Sigmund;
    • Jiang Wang;
    • Phelps, Mitch;
    • Jianying Zhang;
    • Beattie, Christine E.;
    • Baiocchi, Robert;
    • Kaur, Balveen
    Publication type:
    Article
    15
    16

    Recent advances in intradural spinal tumors.

    Published in:
    Neuro-Oncology, 2018, v. 20, n. 6, p. 729, doi. 10.1093/neuonc/nox230
    By:
    • Abd-El-Barr, Muhammad M.;
    • Huang, Kevin T.;
    • Moses, Ziev B.;
    • Iorgulescu, J. Bryan;
    • Chi, John H.
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23